NO162470C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre.Info
- Publication number
- NO162470C NO162470C NO842224A NO842224A NO162470C NO 162470 C NO162470 C NO 162470C NO 842224 A NO842224 A NO 842224A NO 842224 A NO842224 A NO 842224A NO 162470 C NO162470 C NO 162470C
- Authority
- NO
- Norway
- Prior art keywords
- dimetylamino
- tiazol
- 7beta
- ceph
- tetrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58099212A JPS59225192A (ja) | 1983-06-02 | 1983-06-02 | セフアロスポリンエステル誘導体 |
JP59076834A JPS60218394A (ja) | 1984-04-16 | 1984-04-16 | セフアロスポリンエステル誘導体 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO842224L NO842224L (no) | 1984-12-03 |
NO162470B NO162470B (no) | 1989-09-25 |
NO162470C true NO162470C (no) | 1990-01-10 |
Family
ID=26417948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO842224A NO162470C (no) | 1983-06-02 | 1984-06-01 | Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5120841A (es) |
EP (1) | EP0128029B1 (es) |
KR (1) | KR910008350B1 (es) |
AR (2) | AR240825A1 (es) |
AT (1) | ATE40691T1 (es) |
AU (1) | AU566096B2 (es) |
BG (1) | BG60500B2 (es) |
CA (1) | CA1216285A (es) |
DE (1) | DE3476662D1 (es) |
DK (1) | DK273784A (es) |
ES (4) | ES8506577A1 (es) |
FI (1) | FI75574C (es) |
GR (1) | GR79941B (es) |
HK (1) | HK9492A (es) |
HU (1) | HU192028B (es) |
IN (1) | IN158586B (es) |
MY (1) | MY101993A (es) |
NO (1) | NO162470C (es) |
NZ (1) | NZ208281A (es) |
PH (1) | PH19575A (es) |
PT (1) | PT78684B (es) |
SG (1) | SG392G (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0010475D0 (en) * | 2000-04-28 | 2000-06-14 | Biochemie Gmbh | Organic compounds |
CN101993449B (zh) * | 2009-08-13 | 2012-10-31 | 丽珠医药集团股份有限公司 | 高纯度头孢替安酯及其二盐酸盐的制备方法 |
CN102241692A (zh) * | 2010-05-14 | 2011-11-16 | 广州白云山制药股份有限公司广州白云山制药总厂 | 溶媒结晶法制备头孢替安酯盐酸盐的方法 |
CN101948476B (zh) * | 2010-09-19 | 2012-07-25 | 苏州致君万庆药业有限公司 | 一种头孢替安酯盐酸盐的制备方法 |
CN102424687A (zh) * | 2011-11-01 | 2012-04-25 | 湖南方盛制药股份有限公司 | 盐酸头孢替安酯的制备方法 |
CN102898441A (zh) * | 2012-10-11 | 2013-01-30 | 南通康鑫药业有限公司 | 一种头孢替安的合成方法 |
CN103012436B (zh) * | 2012-12-04 | 2015-07-01 | 山东鑫泉医药有限公司 | 头孢替安盐酸盐的制备方法 |
CN104031068A (zh) * | 2014-06-11 | 2014-09-10 | 济南诚汇双达化工有限公司 | 一锅法制备盐酸头孢替安酯的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1425933A (en) * | 1972-03-13 | 1976-02-25 | Astra Laekemedel Ab | Cephalosporins |
NZ176206A (en) * | 1973-12-25 | 1978-03-06 | Takeda Chemical Industries Ltd | Cephalosporins |
US4189479A (en) * | 1977-12-22 | 1980-02-19 | Takeda Chemical Industries, Ltd. | Cephalosporin esters |
DE2805794A1 (de) * | 1978-02-11 | 1979-08-16 | Hoechst Ag | Vorrichtung zum biologischen reinigen von abwasser |
JPS6042766B2 (ja) * | 1978-12-09 | 1985-09-25 | 日本化薬株式会社 | 基剤 |
JPS5759894A (en) * | 1980-09-30 | 1982-04-10 | Sankyo Co Ltd | Cephalosporin for oral administration |
JPS5777690A (en) * | 1980-10-31 | 1982-05-15 | Takeda Chem Ind Ltd | Cephalosporin derivative |
JPS58189186A (ja) * | 1982-04-30 | 1983-11-04 | Takeda Chem Ind Ltd | セフアロスポリン誘導体 |
JPS5989691A (ja) * | 1982-11-15 | 1984-05-23 | Takeda Chem Ind Ltd | セフアロスポリンエステル |
US4616008A (en) * | 1984-05-02 | 1986-10-07 | Takeda Chemical Industries, Ltd. | Antibacterial solid composition for oral administration |
-
1984
- 1984-05-25 NZ NZ208281A patent/NZ208281A/en unknown
- 1984-05-28 AU AU28748/84A patent/AU566096B2/en not_active Ceased
- 1984-05-29 CA CA000455318A patent/CA1216285A/en not_active Expired
- 1984-05-29 IN IN371/CAL/84A patent/IN158586B/en unknown
- 1984-05-30 AR AR296794A patent/AR240825A1/es active
- 1984-05-31 HU HU842135A patent/HU192028B/hu not_active IP Right Cessation
- 1984-05-31 GR GR74891A patent/GR79941B/el unknown
- 1984-06-01 FI FI842210A patent/FI75574C/fi not_active IP Right Cessation
- 1984-06-01 PH PH30757A patent/PH19575A/en unknown
- 1984-06-01 NO NO842224A patent/NO162470C/no unknown
- 1984-06-01 DK DK273784A patent/DK273784A/da not_active Application Discontinuation
- 1984-06-01 DE DE8484303704T patent/DE3476662D1/de not_active Expired
- 1984-06-01 AT AT84303704T patent/ATE40691T1/de active
- 1984-06-01 ES ES533051A patent/ES8506577A1/es not_active Expired
- 1984-06-01 EP EP84303704A patent/EP0128029B1/en not_active Expired
- 1984-06-02 KR KR1019840003078A patent/KR910008350B1/ko not_active IP Right Cessation
- 1984-06-06 PT PT78684A patent/PT78684B/pt not_active IP Right Cessation
-
1985
- 1985-03-01 ES ES540839A patent/ES8607317A1/es not_active Expired
- 1985-12-10 ES ES549761A patent/ES8703480A1/es not_active Expired
-
1986
- 1986-06-30 ES ES556838A patent/ES8801287A1/es not_active Expired
-
1987
- 1987-03-18 US US07/027,433 patent/US5120841A/en not_active Expired - Fee Related
- 1987-07-15 AR AR87308151A patent/AR245132A1/es active
- 1987-09-01 MY MYPI87001501A patent/MY101993A/en unknown
-
1992
- 1992-01-02 SG SG3/92A patent/SG392G/en unknown
- 1992-01-30 HK HK94/92A patent/HK9492A/xx not_active IP Right Cessation
-
1994
- 1994-02-14 BG BG098471A patent/BG60500B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO171853C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser | |
NO164418C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin- og kinolin-karboksylsyre-forbindelser. | |
NO159016C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater. | |
NO800858L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater | |
NO162862C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt resinat av en substituert karboksylsyre. | |
NO167200C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive urinstoff-forbindelser. | |
NO162858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater. | |
NO155098C (no) | Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer. | |
NO158534C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater. | |
NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
NO162470C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre. | |
NO152005C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater | |
FI93458B (fi) | Menetelmä terapeuttisesti käyttökelpoisen 7-/2-(2-aminotiatsol-4-yyli)-2-(Z)-hydroksi-iminoasetamido/-3-(metoksimetyyli)-3-kefeemi-4-karboksyylihappo-/ -(2,2-dimetyylipropionyylioksi)etyyli/esterin diastereomeerin I valmistamiseksi | |
NO930829L (no) | Fremgangsmaate for fremstilling av klavulansyresalter | |
NO151500C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater | |
NO168041C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin. | |
IE812915L (en) | ESTERS OF 7ß-SUBSTITUTED CEPH-3-EM-4-CARBOXYLIC ACIDS | |
NO152089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater | |
NO157330C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 3-metylflavon-8-karboksylsyreestere. | |
SE8500965D0 (sv) | Mellanprodukter for framstellning av beta-laktamasinhibitorer | |
NO158673C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. | |
NO159532C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 1-(4-kinolyl)-2-(4-piperidyl)-etanol eller1-(4-kinolyl)-3-(4-piperidyl)-propanol. | |
DK83584D0 (da) | Fremgangsmade til fremstilling af en alfa-chiral carboxylsyre eller en optisk aktiv ester deraf | |
NO170014C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre | |
NO832430L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater |